Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Description
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, and automation.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2022
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
No Way, Noaccess, No Way, Nopepepe, No Way, No Way, Uh Ohhhh, Absolutely Noaccess, Noaccess, Blurry Noaccess, Noaccessforu, Noaccess, Noway Youcantaccess, Nopepepe
Sign in for full access
Founders
Carol Suh, Drew Weissman, Ph.D, Gene Yeo, Giuseppe Ciaramella, Howard Chang, John Maraganore, Kristina Burow, Ravi Majeti